Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.43 USD | -0.90% | -3.48% | -43.38% |
05-29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
05-28 | Cytokinetics Closes $500 Million Stock Offering | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.38% | 5.49B | |
+7.45% | 114B | |
+8.88% | 104B | |
-1.14% | 22.57B | |
-11.49% | 22.5B | |
-10.51% | 17.95B | |
-41.90% | 16.48B | |
-14.90% | 15.82B | |
+2.27% | 13.55B | |
+27.64% | 10.99B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Transcript : Cytokinetics, Incorporated Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 08